{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:37Z","timestamp":1786119337581,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,15]]},"DOI":"10.1097\/tp.0b013e3181af20fd","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T03:34:04Z","timestamp":1249356844000},"page":"435-441","source":"Crossref","is-referenced-by-count":25,"title":["Increased Interleukin-10 Production Without Expansion of CD4+CD25+ T-Regulatory Cells in Early Stable Renal Transplant Patients on Calcineurin Inhibitors"],"prefix":"10.1097","volume":"88","author":[{"given":"Sharad K.","family":"Mittal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sita","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20210211","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.trim.2006.10.001","article-title":"The aetiology and pathogenesis of chronic allograft nephropathy.","volume":"16","author":"Yates","year":"2006","journal-title":"Transpl Immunol"},{"key":"R2-24-20210211","doi-asserted-by":"crossref","first-page":"36","DOI":"10.47102\/annals-acadmedsg.V34N1p36","article-title":"Preventing renal transplant failure.","volume":"34","author":"Vathsala","year":"2005","journal-title":"Ann Acad Med Singapore"},{"key":"R3-24-20210211","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/00007890-199709150-00008","article-title":"Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys.","volume":"64","author":"Kimikawa","year":"1997","journal-title":"Transplantation"},{"key":"R4-24-20210211","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat Immunol"},{"key":"R5-24-20210211","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni1179","article-title":"A well adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3.","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"R6-24-20210211","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1172\/JCI23411","article-title":"An integrated view of suppressor T cell subsets in immunoregulation.","volume":"114","author":"Jiang","year":"2004","journal-title":"J Clin Invest"},{"key":"R7-24-20210211","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1084\/jem.171.1.141","article-title":"Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action.","volume":"171","author":"Hall","year":"1990","journal-title":"J Exp Med"},{"key":"R8-24-20210211","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4(+) CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"key":"R9-24-20210211","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/01.ASN.0000057540.98231.C1","article-title":"Regulatory CD25+ T cells in human kidney transplant recipients.","volume":"14","author":"Salama","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R10-24-20210211","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/01.tp.0000246312.89689.17","article-title":"A potential side effect of cyclosporin A: Inhibition of CD4(+)CD25(+) regulatory T cells in mice.","volume":"82","author":"Wang","year":"2006","journal-title":"Transplantation"},{"key":"R11-24-20210211","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/01.tp.0000179642.03665.dd","article-title":"Calcineurin inhibitor withdrawal in stable kidney transplant patients decreases the donor-specific cytotoxic T lymphocyte precursor frequency.","volume":"80","author":"van der Mast","year":"2005","journal-title":"Transplantation"},{"key":"R12-24-20210211","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood"},{"key":"R13-24-20210211","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.tp.0000229473.95202.50","article-title":"Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.","volume":"82","author":"Segundo","year":"2006","journal-title":"Transplantation"},{"key":"R14-24-20210211","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/clim.2001.5127","article-title":"Predominant IL-10 production in indirect alloreactivity is not associated with rejection.","volume":"101","author":"Spadafora-Ferreira","year":"2001","journal-title":"Clin Immunol"},{"key":"R15-24-20210211","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/rheumatology\/kel089","article-title":"Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood.","volume":"45","author":"Lawson","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R16-24-20210211","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00007890-199305000-00013","article-title":"Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.","volume":"55","author":"Reinsmoen","year":"1993","journal-title":"Transplantation"},{"key":"R17-24-20210211","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1399-3046.2006.00621.x","article-title":"Improved long-term graft function in kidney transplant recipients with donor antigen-specific hyporeactivity.","volume":"11","author":"Ferraris","year":"2007","journal-title":"Pediatr Transplant"},{"key":"R18-24-20210211","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.4049\/jimmunol.159.12.5853","article-title":"Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells.","volume":"159","author":"Marelli-Berg","year":"1997","journal-title":"J Immunol"},{"key":"R19-24-20210211","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.4049\/jimmunol.162.11.6401","article-title":"Induction of T cell anergy by low numbers of agonist ligands.","volume":"162","author":"Korb","year":"1999","journal-title":"J Immunol"},{"key":"R20-24-20210211","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1365-2567.1999.00737.x","article-title":"T-cell anergy induced by clonotype-specific antibodies: Modulation of an autoreactive human T-cell clone in vitro.","volume":"96","author":"Steenbakkers","year":"1999","journal-title":"Immunology"},{"key":"R21-24-20210211","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1097\/01.ASN.0000042163.73539.D4","article-title":"Reversibility with interleukin-2 suggests that T cell anergy contributes to donor-specific hyporesponsiveness in renal transplant patients.","volume":"13","author":"Ng","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R22-24-20210211","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/01.tp.0000172217.97072.54","article-title":"Cyclosporine preserves the anergic state of human T cells induced by costimulation blockade in vitro.","volume":"80","author":"Koenen","year":"2005","journal-title":"Transplantation"},{"key":"R23-24-20210211","first-page":"1425","article-title":"Induction of T-cell anergy by OKT3 requires cyclosporine-insensitive activation signals.","volume":"27","author":"Willems","year":"1995","journal-title":"Transplant Proc"},{"key":"R24-24-20210211","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/15260","article-title":"Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.","volume":"5","author":"Wells","year":"1999","journal-title":"Nat Med"},{"key":"R25-24-20210211","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/15256","article-title":"Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance.","volume":"5","author":"Li","year":"1999","journal-title":"Nat Med"},{"key":"R26-24-20210211","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/blood-2006-01-0329","article-title":"Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.","volume":"108","author":"Zeiser","year":"2006","journal-title":"Blood"},{"key":"R27-24-20210211","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.healun.2006.03.021","article-title":"Donor-specific cytotoxic hyporesponsiveness associated with high interleukin-10 messenger RNA expression in cardiac allograft patients.","volume":"25","author":"Dijke","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R28-24-20210211","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1399-0012.2006.00584.x","article-title":"Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients.","volume":"21","author":"Baan","year":"2007","journal-title":"Clin Transplant"},{"key":"R29-24-20210211","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor.","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"R30-24-20210211","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.172.8.4733","article-title":"A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells.","volume":"172","author":"Dillon","year":"2004","journal-title":"J Immunol"},{"key":"R31-24-20210211","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.4049\/jimmunol.169.7.3652","article-title":"Microbial recognition via Toll-like receptor-dependent and-independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering.","volume":"169","author":"Edwards","year":"2002","journal-title":"J Immunol"},{"key":"R32-24-20210211","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.4049\/jimmunol.177.11.7551","article-title":"Macrophages and myeloid DC, but not plasmacytoid DC, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals.","volume":"177","author":"Boonstra","year":"2006","journal-title":"J Immunol"},{"key":"R33-24-20210211","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nri2097","article-title":"TH1 cells control themselves by producing interleukin-10.","volume":"7","author":"O\u2019Garra","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R34-24-20210211","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol Rev"},{"key":"R35-24-20210211","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nri2137","article-title":"What does the future hold for cell-based tolerogenic therapy?","volume":"7","author":"Bluestone","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R36-24-20210211","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1529-0131(200201)46:1<42::AID-ART10026>3.0.CO;2-A","article-title":"Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes.","volume":"46","author":"Cho","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R37-24-20210211","first-page":"324","article-title":"Divergent effect of cyclosporine on Th1\/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis.","volume":"27","author":"Kim","year":"2000","journal-title":"J Rheumatol"},{"key":"R38-24-20210211","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.177.2.551","article-title":"In-vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: Differential modulation by cyclosporin A.","volume":"177","author":"Durez","year":"1993","journal-title":"J Exp Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e3181af20fd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:00:55Z","timestamp":1786039255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200908150-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,15]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181af20fd","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8,15]]}}}